Trials / Completed
CompletedNCT01841749
Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast
Management of Ductal Carcinoma in Situ (DCIS) or Pure Micro-invasive (DCIS-MI) Extended Breast, Axillary Node Sentinel Site (GAS) When the Diagnosis is Made by Biopsy and Treatment by Mastectomy Immediately. Descriptive Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 228 (actual)
- Sponsor
- Institut Bergonié · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
When invasive components are discovered at mastectomy for vacuum-assisted biopsy (VAB)-diagnosed ductal carcinoma in situ (DCIS), the only option available is axillary lymph node dissection (ALND). The aim of this prospective multicenter trial was to determine the benefit of performing upfront sentinel lymph node (SLN) biopsy for these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | sentinel node biopsy and mastectomy | sentinel node biopsy and mastectomy |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2013-04-26
- Last updated
- 2025-09-12
- Results posted
- 2025-09-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01841749. Inclusion in this directory is not an endorsement.